AI assistant
NATIONAL RESEARCH CORP — Director's Dealing 2018
Apr 18, 2018
33341_dirs_2018-04-18_d30550c1-0149-45d3-92f6-860d4c8cd3ca.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NATIONAL RESEARCH CORP (NRCIA/B)
CIK: 0000070487
Period of Report: 2018-04-17
Reporting Person: Berwick Donald M (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-04-17 | Common Stock | A | 5090 | — | Acquired | 5090 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-04-17 | Director Stock Option (Right to Buy) | $32.09 | D | 6000 | Disposed | 2025-10-21 | Class B Common Stock (6000) | Direct |
| 2018-04-17 | Director Stock Option (Right to Buy) | $37.78 | D | 6000 | Disposed | 2026-05-11 | Class B Common Stock (6000) | Direct |
| 2018-04-17 | Director Stock Option (Right to Buy) | $44.47 | D | 6000 | Disposed | 2027-05-09 | Class B Common Stock (6000) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Director Stock Option (Right to Buy) | $15.19 | 2025-10-21 | Common Stock (36000) | 36000 | Direct |
| Director Stock Option (Right to Buy) | $14.19 | 2026-05-11 | Common Stock (36000) | 36000 | Direct |
| Director Stock Option (Right to Buy) | $24.35 | 2027-05-09 | Common Stock (36000) | 36000 | Direct |
Footnotes
F1: On April 17, 2018, the Issuer completed a recapitalization whereby the Issuer exchanged one share of its then-existing class A common stock, plus $19.59 in cash, without interest, for each share of its then-existing class B common stock and, following such exchange, each share of class A common stock was reclassified as a share of Common Stock (the "Recapitalization").
F2: Pursuant to the Recapitalization, all outstanding options to purchase class B common stock were vested in full and cancelled. In exchange for the option, the reporting person received one share of common stock, plus $19.59 in cash for each class B option, less the exercise price per share of the option.